Upgrade to SI Premium - Free Trial

'Caris Life Sciences Inc (CAI) is out best value story'; PT Lowered to $31 at TD Cowen

April 13, 2026 8:49 AM
TD Cowen analyst Dan Brennan lowered the price target on Caris Life Sciences Inc (NASDAQ: CAI) to $31.00 (from $35.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change